DOI: 10.1002/pds.5760 ISSN: 1053-8569

Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus

Charles E. Gaber, Abdullah I. Abdelaziz, Jyotirmoy Sarker, Jennifer L. Lund, Evan S. Dellon, Cary C. Cotton, Swathi Eluri, Nicholas J. Shaheen
  • Pharmacology (medical)
  • Epidemiology



In the United States, clinical guidelines recommend daily use of proton pump inhibitors (PPIs) amongst individuals diagnosed with Barrett's esophagus to decrease the risk of progression to dysplasia and neoplasia. Prior studies documenting adherence to PPIs in this population have not characterized heterogeneity in adherence patterns. Factors that may relate to adherence are incompletely described.


We used administrative claims data from the Merative MarketScan Commercial Claims and Encounters database to conduct a retrospective study of adherence to prescription PPIs. A cohort of individuals diagnosed with incident Barrett's esophagus between 2010 and 2019 was identified. Group‐based trajectory models were generated to detect longitudinal adherence subgroups.


79 701 individuals with a new diagnosis of Barrett's esophagus were identified. The best fitting model detected five distinct adherence trajectory groups: consistently high (44% of the population), moderate decline (18%), slow decline (12%), rapid decline (10%), and decline‐then‐increase (16%). Compared to individuals starting PPIs, those already using PPIs were less likely to have a declining adherence pattern. Other factors associated with membership in a declining adherence group included (but were not limited to): female sex, having a past diagnosis of anxiety or depression, and having one or more emergency department visits in the past year.


Using an exploratory method, we detected heterogeneity in adherence to prescription PPIs. Less than half of individuals were classified into the consistently high adherence group, suggesting that many individuals with Barrett's esophagus receive inadequate pharmacologic therapy.

More from our Archive